The resveratrol analog 4,4′-dihydroxy-trans-stilbene suppresses transformation in normal mouse fibroblasts and inhibits proliferation and invasion of human breast cancer cells

Carcinogenesis

Volumn 33, Issue 11, 2012, Pages 2172-2180

  Maccario, Cristina ^a   Savio, Monica ^a   Ferraro, Daniela ^a   Bianchi, Livia ^a   Pizzala, Roberto ^a   Pretali, Luca ^a   Forti, Luca ^b   Stivala, Lucia Anna ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; 4,4' DIHYDROXY TRANS STILBENE; ACTIN; GELATINASE A; GELATINASE B; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P21; PROTEIN P53; RESVERATROL; RETINOBLASTOMA PROTEIN; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; UVOMORULIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL ADHESION; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; COLLAGEN TYPE I; FEMALE; FIBROBLASTS; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; STILBENES; TUMOR STEM CELL ASSAY; WOUND HEALING;

EID: 84868613224     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs244     Document Type: Article

References (40)

1. Cucciolla, V. et al. (2007) Resveratrol: from basic science to the clinic. Cell Cycle, 6, 2495-2510.
2. Kimura, Y. et al. (1985) Effects of stilbene derivates on arachidonate metabolism in leukocytes. Biochim. Biophys. Acta, 837, 209-212.
3. Rotondo, S. et al. (1998) Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br. J. Pharmacol., 123, 1691-1699.
4. Jang, D.S. et al. (1999) Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production. Biochem. Pharmacol., 57, 705-712.
5. Pace-Asciak, C.R. et al. (1995) The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin. Chim. Acta, 235, 207-219.
6. Pace-Asciak, C.R. et al. (1996) Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin. Chim. Acta, 246, 163-182.
7. Klinge, C.M. et al. (2008) Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J., 22, 2185-2197.
8. Jang, M. et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220.
9. Mgbonyebi, O.P. et al. (1998) Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int. J. Oncol., 12, 865-869.
10. Hsieh, T.C. et al. (1999) Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Int. J. Oncol., 15, 245-252.
11. Frankel, E.N. et al. (1993) Inhibition of human LDL oxidation by resveratrol. Lancet, 341, 1103-1104.
12. Kerry, N.L. et al. (1997) Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro. Atherosclerosis, 135, 93-102.
13. MacCarrone, M. et al. (1999) Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur. J. Biochem., 265, 27-34.
14. Szewczuk, L.M. et al. (2004) Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J. Biol. Chem., 279, 22727-22737.
15. Delmas, D. et al. (2006) Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr. Drug Targets, 7, 423-442.
16. Huang, C. et al. (1999) Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis, 20, 237-242.
17. She, Q.B. et al. (2001) Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res., 61, 1604-1610.
18. Lee, K.W. et al. (2008) The resveratrol analogue 3, 5, 3', 4', 5'-pentahydroxytrans-stilbene inhibits cell transformation via MEK. Int. J. Cancer, 123, 2487-2496.
19. Sun, C. et al. (2006) Resveratrol downregulates the constitutional activation of nuclear factor-kappaB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of the cell cycle, and induction of apoptosis. Cancer Genet. Cytogenet., 165, 9-19.
20. Wu, H. et al. (2008) Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells. Biomed. Pharmacother., 62, 611-621.
21. Weng, C.J. et al. (2012) Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat. Rev., 38, 76-87.
22. Stivala, L.A. et al. (2001) Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J. Biol. Chem., 276, 22586-22594.
23. Fang, J.G. et al. (2002) Antioxidant effects of resveratrol and its analogues against the free-radical-induced peroxidation of linoleic acid in micelles. Chemistry, 8, 4191-4198.
24. Cai, Y.J. et al. (2003) Inhibition of free radical-induced peroxidation of rat liver microsomes by resveratrol and its analogues. Biochim. Biophys. Acta, 1637, 31-38.
25. Cheng, J.C. et al. (2006) Structure-activity relationship studies of resveratrol and its analogues by the reaction kinetics of low density lipoprotein peroxidation. Bioorg. Chem., 34, 142-157.
26. Fang, H. et al. (2001). Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem. Res. Toxicol., 14, 280-294.
27. Balan, K.V. et al. (2006) Proteasome-independent down-regulation of estrogen receptor-alpha (ERalpha) in breast cancer cells treated with 4, 4'-dihydroxy-trans-stilbene. Biochem. Pharmacol., 72, 573-581.
28. Savio, M. et al. (2009) The resveratrol analogue 4, 4'-dihydroxy-trans-stilbene inhibits cell proliferation with higher efficiency but different mechanism from resveratrol. Int. J. Biochem. Cell Biol., 41, 2493-2502.
29. Locatelli, G.A. et al. (2005) Inhibition of mammalian DNA polymerases by resveratrol: mechanism and structural determinants. Biochem. J., 389, 259-268.
30. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
31. Muscella, A. et al. (2010) Sublethal concentrations of the platinum(II) complex [Pt(O, O'-acac)(γ-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells. Br. J. Pharmacol., 160, 1362-1377.
32. Baur, J.A. et al. (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov., 5, 493-506.
33. Meeran, S.M. et al. (2008) Cell cycle control as basis for cancer chemoprevention through dietary agents. Front. Biosci., 13, 2191-2202.
34. Pozo-Guisado, E. et al. (2002) The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem. Pharmacol., 64, 1375-1386.
35. Hsieh, T.C. et al. (2011) Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin αVβ3. Int. J. Cancer, 129, 2732-2743.
36. Zheng, L.F. et al. (2006) DNA damage induced by resveratrol and its synthetic analogues in the presence of Cu (II) ions: mechanism and structure-activity relationship. Free Radic. Biol. Med., 41, 1807-1816.
37. Arima, Y. et al. (2008) Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition. Cancer Res., 68, 5104-5112.
38. Liu, J.F. et al. (2002) FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem. Biophys. Res. Commun., 293, 1174-1182.
39. Woo, J.H. et al. (2004) Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene, 23, 1845-1853.
40. Kimura, Y. et al. (2008) Antitumor activities of synthetic and natural stilbenes through antiangiogenic action. Cancer Sci., 99, 2083-2096.